Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer
byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th
Updated on: December 26,2023
10

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer
byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th
Updated on:December 26,2023
10
